These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 6276746)

  • 1. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.
    Riggs BL; Seeman E; Hodgson SF; Taves DR; O'Fallon WM
    N Engl J Med; 1982 Feb; 306(8):446-50. PubMed ID: 6276746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
    Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ
    N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium fluoride in the treatment of osteoporosis.
    Power GR; Gay JD
    Clin Invest Med; 1986; 9(1):41-3. PubMed ID: 3955920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fracture incidence in 803 women with postmenopausal osteoporosis under drug treatment].
    Cronenberg A; Minkus A; Bremer G; Keck E
    Z Orthop Ihre Grenzgeb; 1993; 131(1):70-4. PubMed ID: 8480444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of vertebral osteoporosis. Use of sodium fluoride and sodium monofluorophosphate in combination with calcium].
    Meunier PJ
    Fortschr Med; 1990 Jan; 108(1):45-8. PubMed ID: 2179080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
    Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
    J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Our experience in the treatment of post-menopausal osteoporosis (author's transl)].
    Rico Lenza H; Espinós Pérez D
    Med Clin (Barc); 1982 Apr; 78(8):322-5. PubMed ID: 7087600
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of treatments by calcium and sex hormones on vertebral fracturing in osteoporosis.
    Almustafa M; Doyle FH; Gutteridge DH; Hand DJ; Davis TM; Spinks TJ; Freemantle C; Joplin GF
    Q J Med; 1992 Apr; 83(300):283-94. PubMed ID: 1321457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence.
    Riggs BL; Hodgson SF; Hoffman DL; Kelly PJ; Johnson KA; Taves D
    JAMA; 1980 Feb; 243(5):446-9. PubMed ID: 7351765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of osteoporosis.
    Melick RA
    Med J Aust; 1986 Jun; 144(12):645-7. PubMed ID: 3520261
    [No Abstract]   [Full Text] [Related]  

  • 11. Variations in treatment of postmenopausal osteoporosis.
    Schwartz M; Anwah I; Levy RN
    Clin Orthop Relat Res; 1985; (192):180-4. PubMed ID: 3967420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with Ossin].
    Kocián J
    Med Pregl; 1980; 33(7-8):309-16. PubMed ID: 7010110
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride.
    Hedlund LR; Gallagher JC
    J Bone Miner Res; 1989 Apr; 4(2):223-5. PubMed ID: 2728925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative effects of sodium fluoride and hormonal replacement therapy on bone metabolism in osteoporotic women with high fracture risk. Results of monitoring for 2 years].
    Pouillès JM; Trémollières F; Ribot C
    Rev Rhum Mal Osteoartic; 1992 Feb; 59(2):103-13. PubMed ID: 1604221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium fluoride treatment of bone disease in multiple myeloma.
    Gardner FH
    Tex Med; 1984 Dec; 80(12):28-30. PubMed ID: 6096981
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous hip fractures in fluoride-treated patients: potential causative factors.
    Gutteridge DH; Price RI; Kent GN; Prince RL; Michell PA
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S205-15. PubMed ID: 2339631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.
    Adami S; Isaia G; Luisetto G; Minisola S; Sinigaglia L; Gentilella R; Agnusdei D; Iori N; Nuti R;
    J Bone Miner Res; 2006 Oct; 21(10):1565-70. PubMed ID: 16995811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.
    Storm T; Thamsborg G; Steiniche T; Genant HK; Sørensen OH
    N Engl J Med; 1990 May; 322(18):1265-71. PubMed ID: 2109197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of osteoporosis with sodium fluoride and calcium: effects on vertebral fracture incidence and bone histomorphometry.
    Lane JM; Healey JH; Schwartz E; Vigorita VJ; Schneider R; Einhorn TA; Suda M; Robbins WC
    Orthop Clin North Am; 1984 Oct; 15(4):729-45. PubMed ID: 6493736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium and vitamin D--for whom and when.
    Prince RL
    Menopause Int; 2007 Mar; 13(1):35-7. PubMed ID: 17448266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.